urinary icontinence/bph practice questions

Which of the following pathologic changes causes stress urinary incontinence?

a. Urethral hypoactivity

b. Detrusor muscle hypoactivity

c. Detrusor muscle hyperactivity

d. Urethral hyperactivity

Urethral hypoactivity

Which of the following medications for urge urinary incontinence is least likely to cause dry mouth?

a. Tolterodine

b. Mirabegron

c. Oxybutynin

d. Solifenacin

Mirabegron

Which of the following medications for BPH is most likely to cause hypotension?

a. Finasteride

b. Mirabegron

c. Tamsulosin

d. Terazosin

Terazosin

Which of the following is the best indicator for the use of finasteride in those with BPH?

a. At risk for hypotension

b. Concurrent erectile dysfunction

c. Enlarged prostate (PSA ≥ 1.4 mcg/L)

d. Frequent episodes of nocturia

Enlarged prostate (PSA ≥ 1.4 mcg/L)

Flibanserin is not to be taken at the same as ____ is consumed due to the risk of hypotension.

a. CBD oil

b. alcohol

c. cheese

d. turkey

alcohol

Oral oxybutynin is excreted in the:

a. sweat.

b. saliva.

c. feces.

d. urine.

urine.

The half-life of tamsulosin in those with BPH is:

a. 2-3 days.

b. 30-60 min.

c. 6-8 hrs.

d. 14-15 hrs.

14-15 hrs.

The half-life of tamsulosin in normal patients is:

a. 2-3 days.

b. 30-60 min.

c. 6-8 hrs.

d. 14-15 hrs.

6-8 hrs.

Finasteride is a:

a. type II 5-alpha reductase inhibitor.

b. uroselective alpha-blocker.

c. selective M3 muscarinic receptor antagonist.

d. phosphodiesterase-3 inhibitor.

type II 5-alpha reductase inhibitor.

Solifenacin is a:

a. type II 5-alpha reductase inhibitor.

b. uroselective alpha-blocker.

c. selective M3 muscarinic receptor antagonist.

d. phosphodiesterase-3 inhibitor.

selective M3 muscarinic receptor antagonist.

Terazosin:

a. is excreted primarily in the urine.

b. has a half-life of 72 hours.

c. is hepatically metabolized.

d. undergoes oxidation to the active metabolite.

is hepatically metabolized.